180 Life Sciences Corp.

NASDAQ (USD): 180 Life Sciences Corp. (ATNF)

Last Price

9.10

Today's Change

+7.58 (498.68%)

Day's Change

8.27 - 17.75

Trading Volume

62,107,367

Overview

Market Cap

8 Million

Shares Outstanding

969,601

Avg Volume

63,996

Avg Price (50 Days)

1.77

Avg Price (200 Days)

2.43

PE Ratio

-0.81

EPS

-11.20

Earnings Announcement

07-Nov-2024

Previous Close

1.52

Open

14.25

Day's Range

8.27 - 17.75

Year Range

1.16 - 17.75

Trading Volume

62,143,196

Price Change Highlight

1 Day Change

489.47%

5 Day Change

589.23%

1 Month Change

389.62%

3 Month Change

286.21%

6 Month Change

505.41%

Ytd Change

129.16%

1 Year Change

-9.49%

3 Year Change

-99.61%

5 Year Change

-98.65%

10 Year Change

-99.38%

Max Change

-99.38%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment